Inflammatory diseases of the nasal cavity and paranasal sinuses. Role of topical therapy products
https://doi.org/10.21518/2079-701X-2016-18-42-44
Abstract
The article deals with application of local antibacterial therapy for the most frequent acute and chronic inflammatory diseases of the nasal cavity and paranasal sinuses. Advantages of the topic method of etiotropic therapy for this pathology are analyzed, indications for use of antibacterial drugs and the most frequently made errors in this case are discussed. A necessity to indicate topic antebacterial drugs in the post-surgical period to patients who underwent surgical intervention on nasal cavity and paranasal sinuses structures is specified.
About the Authors
V. M. Svistushkin
Sechenov First Moscow State Medical University of the Ministry of Health of Russia
Russian Federation
MD, Prof.
Russian Federation
MD, Prof.
E. V. Sinkov
Sechenov First Moscow State Medical University of the Ministry of Health of Russia
Russian Federation
PhD in medicine
Russian Federation
PhD in medicine
References
1. Gwaltney JM. The common cold. In: Mandell G.L., Bennet J.E., Dolin R., eds., Principles and practice of infectious diseases. New York: Churchill Livingstone, 1995.
2. Яковлев С.В. Рациональная антибактериальная терапия инфекций верхних дыхательных путей: значение системных и местных антибиотиков. Cons. Med., 2007, 3: 16-22. [Yakovlev S.V. Rational antibacterial therapy of infections of upper respiratory ways: meaning of systemic and topical antibiotics. Cons. Md., 2007, 3: 16-22].
3. Snow V, Gonzales R. Principles of appropriate antibiotic use for treatment of nonspecific upper respiratory tract infections in adults. Ann Intern Med, 2001, 134(6): 4.
4. WHO: Antimicrobial resistance: global report on surveillance 2014. April 2014.
5. Субботина М.В. Топическая терапия воспалительных заболеваний верхних дыхательных путей. Cons. Med., 2010, 12(11): 16-21. [Subbotina M.V. Topical therapy of inflammatory diseases of upper respiratory ways. Cons. Med., 2010, 12 (11): 16-21].
6. Mosges R, Spaeth J, Berger K et al. Topical treatment of rhinosinusitis with fusafungine nasal spray. Arzneim Forsch Drug Res, 2002, 12: 877-83.
7. Cвистушкин В.М., Овчинников А.Ю., Никифорова Г.Н. Воспаление после операций в полости носа и околоносовых пазухах: необходимость медикаментозного регулирования. Росс. ринол., 2007, 2: 56-61. [Svistush kin V.M., Ovchinnikov A.Y., Nikiforova G.N. Inflammation after surgery in the nasal cavity and paranasal sinuses: necessity of drug regulation. Ross. Rinol., 2007, 2: 56-61].
8. Федосеев Г.Б. Механизмы воспаления бронхов и легких и противовоспалительная терапия. СПб.: Нормедиздат, 1998: 687. [ Fedoseev G.B. Mechanisms of bronchi and lungs inflammation and anti-inflammatory therapy. SPb: Normed-izdat., 1998: 687].
Review
For citations:
Svistushkin VM, Sinkov EV. Inflammatory diseases of the nasal cavity and paranasal sinuses. Role of topical therapy products. Meditsinskiy sovet = Medical Council. 2016;(18):42-44. (In Russ.) https://doi.org/10.21518/2079-701X-2016-18-42-44
Views:
905
Email this article 